<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:45070841-bc41-4ebc-80ff-faad6e115441,g:dd5aaf1a-775d-4955-a484-410cae10b66c,d:362f15f065674ff6999b5e3e34040adc--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rna-20230228</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY184Ni9mcmFnOjhlOWIxNWYxNjAwMDRkNzU5NTU3OTRkNWE4NmFiZTkzL3RhYmxlOjM5NjNjNTU3MTM3YjQ2NGY4MzYxNGUzZTNhNTBkNmZmL3RhYmxlcmFuZ2U6Mzk2M2M1NTcxMzdiNDY0ZjgzNjE0ZTNlM2E1MGQ2ZmZfMC0xLTEtMS04MjUy_fb63a638-0ad6-4c48-ab8f-cb4cdd7b663f">0001599901</ix:nonNumeric><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY184Ni9mcmFnOjhlOWIxNWYxNjAwMDRkNzU5NTU3OTRkNWE4NmFiZTkzL3RhYmxlOjM5NjNjNTU3MTM3YjQ2NGY4MzYxNGUzZTNhNTBkNmZmL3RhYmxlcmFuZ2U6Mzk2M2M1NTcxMzdiNDY0ZjgzNjE0ZTNlM2E1MGQ2ZmZfMS0xLTEtMS04MjU1_dd310156-c46b-4bca-9363-99ef4f6f7e6a">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rna-20230228.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599901</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-28</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i362f15f065674ff6999b5e3e34040adc_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjIy_56ed0c7f-9537-43e0-bcbb-461f976941e5">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjIz_e66aa237-23aa-4c47-9829-a827ec03e887">February 28, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjI0_6129fea6-db97-462c-a9d1-d70cdda911a9">AVIDITY BIOSCIENCES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6MDM4ODM3YWYxMWEwNDFmMTg2NzE2ZDAwMjFjMDY3ODEvdGFibGVyYW5nZTowMzg4MzdhZjExYTA0MWYxODY3MTZkMDAyMWMwNjc4MV8wLTAtMS0xLTgxOTU_ac51290a-31b1-4e16-a514-eb4f44ac9d27">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6MDM4ODM3YWYxMWEwNDFmMTg2NzE2ZDAwMjFjMDY3ODEvdGFibGVyYW5nZTowMzg4MzdhZjExYTA0MWYxODY3MTZkMDAyMWMwNjc4MV8wLTEtMS0xLTgxOTc_cf31aa4e-e3f4-4004-a161-22e589e11be9">001-39321</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6MDM4ODM3YWYxMWEwNDFmMTg2NzE2ZDAwMjFjMDY3ODEvdGFibGVyYW5nZTowMzg4MzdhZjExYTA0MWYxODY3MTZkMDAyMWMwNjc4MV8wLTItMS0xLTgxOTk_27e05910-fe2e-4d08-81f9-67e58a972c3e">46-1336960</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjI1_82ee0d44-87e8-4d10-813f-5fce0a27bbbf">10578 Science Center Drive</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjI2_d66a62d6-7d6f-4669-8b95-f44d06e50d21">Suite 125</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjI3_8aef2ec4-84ff-428e-9263-6e946fd83732">San Diego</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjI4_d8b6b838-32be-47f6-ad06-63c7d247da22">California</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjI5_ec21d71c-1a3e-4aa3-933b-afe13d324816">92121</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjMw_d89a7637-c9bd-4d6d-9cca-a3180274ff09">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjMx_058717b2-aa61-47f3-8c36-6f5be3d9edf3">401-7900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, include area code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6NzU5ZjIxNjc0N2Q2NDAyYWE5MTA5YjZjZWYxNzE4ZmYvdGFibGVyYW5nZTo3NTlmMjE2NzQ3ZDY0MDJhYTkxMDliNmNlZjE3MThmZl8wLTAtMS0xLTgyMTY_07068ee5-9db3-4d58-9c1d-1d159c8af2dc">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6NzU5ZjIxNjc0N2Q2NDAyYWE5MTA5YjZjZWYxNzE4ZmYvdGFibGVyYW5nZTo3NTlmMjE2NzQ3ZDY0MDJhYTkxMDliNmNlZjE3MThmZl8yLTAtMS0xLTgyMTk_ce42683b-e3e3-4aff-aca0-8c917d58978c">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6NzU5ZjIxNjc0N2Q2NDAyYWE5MTA5YjZjZWYxNzE4ZmYvdGFibGVyYW5nZTo3NTlmMjE2NzQ3ZDY0MDJhYTkxMDliNmNlZjE3MThmZl80LTAtMS0xLTgyMjE_1103d100-a72c-4f99-9372-3819500701fd">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6NzU5ZjIxNjc0N2Q2NDAyYWE5MTA5YjZjZWYxNzE4ZmYvdGFibGVyYW5nZTo3NTlmMjE2NzQ3ZDY0MDJhYTkxMDliNmNlZjE3MThmZl82LTAtMS0xLTgyMjM_655d7c86-0521-41f9-babe-12c9e7f390e6">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6Y2QzZGM0MWY3ZWNlNDljNzgzMTA3YTlhOTgzMDYxMTIvdGFibGVyYW5nZTpjZDNkYzQxZjdlY2U0OWM3ODMxMDdhOWE5ODMwNjExMl8xLTAtMS0xLTgyMjU_93ba4393-4534-4c05-8dfe-c9c8430fac01">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6Y2QzZGM0MWY3ZWNlNDljNzgzMTA3YTlhOTgzMDYxMTIvdGFibGVyYW5nZTpjZDNkYzQxZjdlY2U0OWM3ODMxMDdhOWE5ODMwNjExMl8xLTItMS0xLTgyMjg_5d660e39-6735-4289-8ce1-afbe8322d2cd">RNA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGFibGU6Y2QzZGM0MWY3ZWNlNDljNzgzMTA3YTlhOTgzMDYxMTIvdGFibGVyYW5nZTpjZDNkYzQxZjdlY2U0OWM3ODMxMDdhOWE5ODMwNjExMl8xLTQtMS0xLTgyMzA_ab71773b-e386-4305-847b-819b76a11c4a">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92ab3afd1b6f48c8921694220625193e_D20230228-20230228" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MmYxNWYwNjU2NzRmZjY5OTliNWUzZTM0MDQwYWRjL3NlYzozNjJmMTVmMDY1Njc0ZmY2OTk5YjVlM2UzNDA0MGFkY18xL2ZyYWc6NzdlNmQ5YzM1YzMxNGE0YWI5ODQwNjRhYjBiN2Q3MmQvdGV4dHJlZ2lvbjo3N2U2ZDljMzVjMzE0YTRhYjk4NDA2NGFiMGI3ZDcyZF8xNjQ5MjY3NDQzMjMy_706d22a3-3f5c-415f-853c-6cf112baa3b9">o</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i362f15f065674ff6999b5e3e34040adc_4"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-indent:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2023, Avidity Biosciences, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-indent:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with General Instruction&#160;B.2 of&#160;Form&#160;8-K,&#160;the information in this Current Report on&#160;Form&#160;8-K,&#160;including Exhibit&#160;99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing.</span></div><div id="i362f15f065674ff6999b5e3e34040adc_7"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01. Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm">Press Release issued on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm">February</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm">8, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="rna-20230228xexx991.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i362f15f065674ff6999b5e3e34040adc_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AVIDITY BIOSCIENCES, INC.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February 28, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Michael F. MacLean</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael F. MacLean<br/>Chief Financial and Chief Business Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "rna-20230228.htm", "description": "8-K", "secsgml_size_bytes": 35125}]
{"company-data": {"conformed-name": "Avidity Biosciences, Inc.", "cik": "0001599901", "assigned-sic": "2834", "irs-number": "461336960", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-39321", "film-number": "23685340"}, "business-address": {"street1": "10578 SCIENCE CENTER DRIVE", "street2": "SUITE 125", "city": "SAN DIEGO", "state": "CA", "zip": "92121", "phone": "858-401-7900"}, "mail-address": {"street1": "10578 SCIENCE CENTER DRIVE", "street2": "SUITE 125", "city": "SAN DIEGO", "state": "CA", "zip": "92121"}, "former-company": [{"former-conformed-name": "Avidity Biosciences LLC", "date-changed": "20161227"}, {"former-conformed-name": "Avidity NanoMedicines LLC", "date-changed": "20140211"}]}
rna-20230228
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________
FORM
8-K
_________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
February 28, 2023
_________________________________________
AVIDITY BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
_________________________________________
Delaware
001-39321
46-1336960
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
10578 Science Center Drive
,
Suite 125
San Diego
,
California
92121
(Address of principal executive offices) (Zip Code)
(
858
)
401-7900
(Registrant's telephone number, include area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
_________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share
RNA
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 2.02 Results of Operations and Financial Condition.
On February 28, 2023, Avidity Biosciences, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number
Description
99.1
Press Release issued on
February
2
8, 202
3
.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AVIDITY BIOSCIENCES, INC.
Date: February 28, 2023
By:
/s/ Michael F. MacLean
Michael F. MacLean
Chief Financial and Chief Business Officer